Ken Griffin First Trust Nyse Arca Biotechn Call Options Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

Call Options

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2024 Aug 14, 2024	BUY	$141.52 - $156.4 $410,408 - $453,560	2,900 Added 362.5%	3,700 $569,000
Q1 2024 May 15, 2024	BUY	$145.08 - $160.46 $58,032 - $64,184	400 Added 100.0%	800 $123,000
Q4 2023 Feb 14, 2024	SELL	$132.5 - $158.45 $251,750 - $301,055	-1,900 Reduced 82.61%	400 $63,000
Q3 2023 Nov 14, 2023	BUY	$145.69 - $157.89 $101,983 - $110,522	700 Added 43.75%	2,300 $336,000
Q2 2023 Aug 14, 2023	SELL	$151.19 - $159.79 $740,831 - $782,971	-4,900 Reduced 75.38%	1,600 $245,000
Q1 2023 May 15, 2023	BUY	$147.92 - $165.37 $517,719 - $578,795	3,500 Added 116.67%	6,500 $1.01 Million
Q4 2022 Feb 14, 2023	SELL	$132.87 - $159.04 $704,211 - $842,912	-5,300 Reduced 63.86%	3,000 $462,000
Q3 2022 Nov 14, 2022	BUY	$128.6 - $149.75 $1.07 Million - $1.24 Million	8,300 New	8,300 $1.1 Million

Others Institutions Holding FBT

# of Institutions

265

Shares Held

3.83M

Call Options Held

19.1K

Put Options Held

0

About FIRST TRUST NYSE ARCA BIOTECHN

Ticker FBT
Sector ETFs
Industry ETFs

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.